drugset / Trial / NCT02545530
Transdermal Clonidine in Chronic Hemodialysis Patients
RandomizedCrossoverOpen-labelTreatment
Summary
The majority of chronic hemodialysis patients need a combination of several antihypertensive drugs for adequate BP control. The primary objective of this study is to evaluate whether transdermal clonidine can improve blood pressure control or decrease oral antihypertensive agents type or dosage and the secondary objective is to observe incidence of adverse reactions of transdermal clonidine in chronic hemodialysis patients.
Timeline
- Start
- 2015-05
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clonidine | Other / unclassified | 2.5 mg | Other |
Indications
No indication recorded.